Insmed (NASDAQ:INSM – Free Report) had its target price raised by Bank of America from $92.00 to $96.00 in a research note ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback